XNYS · Laboratory Analytical Instruments · S&P 500
$386.11
+$5.27 (+1.38%) today
Open $380.84 High $386.78 Low $376.20 Vol 113K Avg $385.43
52-week price range
Price is 63.1% above its 52-week low and 2.6% below its 52-week high. Trading in the upper half of its annual range — closer to the peak than the base.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.